| 1 |
33911374 | Inherited Manganese Disorders and the Brain: What Neurologists Need to Know. | 2021 Jan-Feb |
2 |
| 2 |
33925013 | Molecular Targets of Manganese-Induced Neurotoxicity: A Five-Year Update. | 2021 Apr 28 |
1 |
| 3 |
34315874 | GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms. | 2021 Jul 27 |
1 |
| 4 |
34446561 | Up-regulation of the manganese transporter SLC30A10 by hypoxia-inducible factors defines a homeostatic response to manganese toxicity. | 2021 Aug 31 |
1 |
| 5 |
34753157 | Manganese Toxicity Associated With Total Parenteral Nutrition: A Review. | 2021 Oct |
1 |
| 6 |
34849276 | Treatable Hereditary Manganese Transport Disorder: Novel SLC30A10 Mutation and its Characteristic Neuroimaging Appearance in Two Siblings. | 2021 Dec |
1 |
| 7 |
34877518 | Atypical presentation of SLC30A10 gene mutation with hypermanganesemia, seizures and polycythemia. | 2021 |
1 |
| 8 |
32392784 | The Functions of ZIP8, ZIP14, and ZnT10 in the Regulation of Systemic Manganese Homeostasis. | 2020 May 7 |
5 |
| 9 |
30272946 | SLC30A10 Mutation Involved in Parkinsonism Results in Manganese Accumulation within Nanovesicles of the Golgi Apparatus. | 2019 Jan 16 |
1 |
| 10 |
30755481 | Zinc transporter 10 (ZnT10)-dependent extrusion of cellular Mn2+ is driven by an active Ca2+-coupled exchange. | 2019 Apr 12 |
2 |
| 11 |
31089831 | Genetic Disorders of Manganese Metabolism. | 2019 May 14 |
2 |
| 12 |
31288771 | A case of dystonia with polycythemia and hypermanganesemia caused by SLC30A10 mutation: a treatable inborn error of manganese metabolism. | 2019 Jul 9 |
2 |
| 13 |
28789954 | Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. | 2018 Jan |
1 |
| 14 |
29382362 | Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system. | 2018 Jan 30 |
1 |
| 15 |
29429640 | Neurotoxicity of manganese: Indications for future research and public health intervention from the Manganese 2016 conference. | 2018 Jan |
1 |
| 16 |
29989630 | Putative metal binding site in the transmembrane domain of the manganese transporter SLC30A10 is different from that of related zinc transporters. | 2018 Aug 15 |
3 |
| 17 |
30619481 | Polymorphisms in Manganese Transporters SLC30A10 and SLC39A8 Are Associated With Children's Neurodevelopment by Influencing Manganese Homeostasis. | 2018 |
1 |
| 18 |
28860195 | Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production. | 2017 Oct 6 |
5 |
| 19 |
26628504 | Common Polymorphisms in the Solute Carrier SLC30A10 are Associated With Blood Manganese and Neurological Function. | 2016 Feb |
1 |
| 20 |
27107558 | Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. | 2016 Oct |
4 |
| 21 |
27226609 | Direct Comparison of Manganese Detoxification/Efflux Proteins and Molecular Characterization of ZnT10 Protein as a Manganese Transporter. | 2016 Jul 8 |
5 |
| 22 |
27307044 | Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity. | 2016 Jul 29 |
5 |
| 23 |
25778823 | Manganese transport disorder: novel SLC30A10 mutations and early phenotypes. | 2015 Jun |
1 |
| 24 |
24576911 | Interleukin-6 enhances manganese accumulation in SH-SY5Y cells: implications of the up-regulation of ZIP14 and the down-regulation of ZnT10. | 2014 Apr |
4 |
| 25 |
23357421 | Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations. | 2013 Mar 1 |
1 |
| 26 |
22341971 | Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. | 2012 Mar 9 |
3 |
| 27 |
22926781 | Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. | 2012 Sep 1 |
1 |